Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Taxotere
Active Ingredient: Docetaxel (trihydrate) 40mg/mL
Dosage Form: Solution for concentrate for infusion
New Zealand Sponsor: Aventis Pharma Limited
Manufacturer(s): Aventis Pharma Specialites, Vitry-Sur-Seine, France
Aventis Pharma, Dagenham, Essex, United Kingdom
Note: This consent is valid for 2 years from 23 May 2002.
Dated this 12th day of April 2002.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).